Newsroom
SNT Biotech
in the news.
Coverage, announcements, and insights on our mission to bring at-home screening to the members who need it most.
Coverage, announcements, and insights on our mission to bring at-home screening to the members who need it most.
5,000 kits mailed, 1,205 completed screenings, a 24% return rate, and 19 members who had polyps removed. See how we ran it for a regional health plan.
Read the case study →
SNT Biotech announced a partnership with Waters Corporation to bring the FDA-cleared BD Onclarity HPV self-collection kit for at-home cervical cancer screening to patients and health plans across the U.S.
Read the announcement →
Founder and CEO Shital Daftari was featured on NBC 5 Chicago's "Tech Trends," discussing how SNT Biotech helps more women complete cervical cancer screening from home.
Watch the segment →How self-collection removes the barriers that keep members from completing cervical screening.
Read more →Why kit return rate, not activity, is the number that actually moves a HEDIS measure.
Read more →Federal coverage requirements take effect in 2027. Here is how to get ahead of it.
Read more →A practical playbook for reaching the Medicaid and MA members everyone else gives up on.
Read more →Most vendors rent a lab network. Why owning ours changes quality and accountability.
Read more →How the same at-home platform closes colorectal, diabetes, and kidney gaps together.
Read more →SNT Biotech is a population health technology and diagnostic screening company headquartered in Plainfield, Illinois. It partners with Medicaid, Medicare Advantage, and commercial health plans to close preventive care gaps through fully integrated at-home screening for cervical, colorectal, diabetes, and kidney health, processed in its own CLIA and COLA accredited laboratory. SNT Biotech is an Inc. 5000 company and a certified minority and women-owned business.
We are happy to provide interviews, data, and a clinician spokesperson.